GlassScriptPhysician profile
Robert Warren Hull
NPI 1174602924
$3,932.12
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,752 · 2020: $420 · 2021: $119 · 2022: $467 · 2023: $144 · 2024: $29.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,908.00 | 2019-2024 | Mitraclip, Amplatzer, Perclose Prostyle |
| Boston Scientific Corporation | $401.16 | 2019-2020 | |
| Medtronic, INC. | $349.60 | 2022 | |
| Sanofi-Aventis U.S. LLC | $167.07 | 2019-2020 | |
| Amgen INC. | $158.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $153.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $143.87 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $139.86 | 2019-2020 | |
| Journey Medical Corporation | $117.59 | 2022 | |
| Lundbeck LLC | $84.91 | 2019-2020 | |
| Gilead Sciences, INC. | $45.12 | 2019 | |
| Atricure, INC. | $44.49 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.46 | 2019 | |
| Philips North America LLC | $31.91 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $31.66 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $30.56 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.94 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $23.50 | 2019-2020 | |
| Pfizer INC. | $19.99 | 2019 | |
| Medtronic Vascular, INC. | $16.10 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.